These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 16619692)
1. Strategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphoma. Rochford R; Feuer G; Orem J; Banura C; Katongole-Mbidde E; Mwanda WO; Moormann A; Harrington WJ; Remick SC East Afr Med J; 2005 Sep; 82(9 Suppl):S155-60. PubMed ID: 16619692 [TBL] [Abstract][Full Text] [Related]
2. Burkitt's lymphoma: single-centre experience with modified BFM protocol. Harris E; Paneesha S; Jackson N; Jones L; Mahendra P Clin Lab Haematol; 2002 Apr; 24(2):111-4. PubMed ID: 11985557 [TBL] [Abstract][Full Text] [Related]
3. Challenges in the management of Burkitt's lymphoma. Levine AM Clin Lymphoma; 2002 Dec; 3 Suppl 1():S19-25. PubMed ID: 12521385 [TBL] [Abstract][Full Text] [Related]
4. Zidovudine: a targeted therapy for endemic Burkitt's lymphoma. Kurokawa M; Andela V; Ghosh S; Barreto JE; Harrington W East Afr Med J; 2005 Sep; 82(9 Suppl):S150-4. PubMed ID: 16619691 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Burkitt's lymphoma in HIV-positive patients. Straus DJ Biomed Pharmacother; 1996; 50(9):447-50. PubMed ID: 8991116 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents]. Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797 [TBL] [Abstract][Full Text] [Related]
7. Burkitt's lymphoma and previous AIDS-defining illnesses are not prognostic factors in AIDS-related non-Hodgkin's lymphoma. Stebbing J; Mandalia S; Palmieri C; Nelson M; Gazzard B; Bower M J Clin Oncol; 2005 Nov; 23(33):8538-40; author reply 8540-1. PubMed ID: 16293885 [No Abstract] [Full Text] [Related]
8. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411 [TBL] [Abstract][Full Text] [Related]
9. Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma. Montoto S; Wilson J; Shaw K; Heath M; Wilson A; McNamara C; Orkin C; Nelson M; Johnson M; Bower M; Cwynarski K AIDS; 2010 Mar; 24(6):851-6. PubMed ID: 20124971 [TBL] [Abstract][Full Text] [Related]
10. Primary ovarian Burkitt's lymphoma: a rare oncological problem in gynaecology: a review of literature. Stepniak A; Czuczwar P; Szkodziak P; Wozniakowska E; Wozniak S; Paszkowski T Arch Gynecol Obstet; 2017 Oct; 296(4):653-660. PubMed ID: 28770352 [TBL] [Abstract][Full Text] [Related]
11. Successful administration of aggressive chemotherapy concomitant to tuberculostatic and highly active antiretroviral therapy in a patient with AIDS-related Burkitt's lymphoma. Lehmann C; Wyen C; Hoffmann C; Fätkenheuer G HIV Med; 2005 Jan; 6(1):51-3. PubMed ID: 15670254 [TBL] [Abstract][Full Text] [Related]
12. Management of AIDS-related lymphoma. Levine AM Curr Opin Oncol; 2008 Sep; 20(5):522-8. PubMed ID: 19106654 [TBL] [Abstract][Full Text] [Related]
14. Burkitt's lymphoma shortly after an acute HIV infection, treated with highly active retroviral treatment. Colebunders R; Dohmen S; Van de Velde A; Pelgrom J; Hermans P Acta Clin Belg; 2001; 56(5):321-2. PubMed ID: 11770227 [No Abstract] [Full Text] [Related]
15. Burkitt's Lymphoma and B-Cell Lymphoma Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma in Patients With HIV: Outcomes in a South African Public Hospital. Sissolak G; Seftel M; Uldrick TS; Esterhuizen TM; Mohamed N; Kotze D J Glob Oncol; 2017 Jun; 3(3):218-226. PubMed ID: 28717763 [TBL] [Abstract][Full Text] [Related]
16. Malignant lymphoma in the HIV-positive patient. Meister A; Hentrich M; Wyen C; Hübel K Eur J Haematol; 2018 Jul; 101(1):119-126. PubMed ID: 29663523 [TBL] [Abstract][Full Text] [Related]
17. β-elemene against Burkitt's lymphoma via activation of PUMA mediated apoptotic pathway. Hu T; Gao Y Biomed Pharmacother; 2018 Oct; 106():1557-1562. PubMed ID: 30119230 [TBL] [Abstract][Full Text] [Related]
18. Favorable response of pediatric AIDS-related Burkitt's lymphoma treated by aggressive chemotherapy. Neumann Y; Toren A; Mandel M; Martinowitz U; Varon D; Ramot B; Ben-Bassat I; Rechavi G Med Pediatr Oncol; 1993; 21(9):661-4. PubMed ID: 8413000 [TBL] [Abstract][Full Text] [Related]